- Li Y, Feng M, Guo T, Wang Z, Zhao Y*, 2023. Tailored beta-lapachone nanomedicines for cancer-specific therapy. Adv Healthc Mater, 12(20): 2300349.
- Li Y, Liu M, Zheng Y, Wang Z*, Zhao Y*, 2023. Coenzyme-depleting nanocarriers for enhanced redox cancer therapy under hypoxia. J Colloid Interface Sci, 641: 135-145.
- Wang Z, Mu X, Yang Q, Luo J, Zhao Y*, 2022. Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha. J Colloid Interface Sci, 628: 106-115.
- Li Y, Qin Y, Shang Y, Li Y, Liu F, Luo J, Zhu J, Guo X, Wang Z, Zhao Y*, 2022. Mechano-responsive leapfrog micelles enable interactive apoptotic and ferroptotic cancer therapy. Adv Func Mater, 32(29): 2112000.
- Zhu J, Guo T, Wang Z*, Zhao Y*, 2022. Triggered Azobenzene-based prodrugs and drug delivery systems. J Control Release, 345, 475-493.
- Li Y#, Feng S#, Dai, P, Liu F, Shang Y, Yang Q, Qin J, Yuchi Z, Wang Z*, Zhao Y*, 2022. Tailored Trojan horse nanocarriers for enhanced redox-responsive drug delivery. J Control Release, 342, 201-209.
- Ma Y, Ye Z, Zhang C, Zhao Y*, Luo H*, Xiao L*, 2022. Curved carbon photo-oxygenation catalysts for the suppression and nanoscopic imaging of β-amyloid peptides fibrillation. Nano Res, 15, 3387-3397.
- Liu F, Zhu J, Dai P, Deng J, Qin J, Yuchi Z, Fan A, Wang Z, Zhao Y*, 2021. Double-lock nanomedicines enable tumor microenvironment-responsive selective anti-tumor therapy. Adv Func Mater, 31(38), 2009157.
- Qin Y, Guo T, Wang Z, Zhao Y*, 2021. The role of iron in doxorubicin-induced cardiotoxicity: recent advances and implication for drug delivery. J Mater Chem B, 9(24): 4793-4803.
- Guo X, Liu F, Deng J, Dai P, Qin Y, Li Z, Wang B, Fan A, Wang Z*, Zhao Y*, 2020. Electron-accepting micelles deplete reduced nicotinamide adenine dinucleotide phosphate and impair two antioxidant cascades for ferroptosis-induced tumor eradication. ACS Nano, in press (doi: 10.1021/acsnano.0c00764).